. Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trials. Alzheimers Dement (N Y). 2024;10(4):e70009. Epub 2024 Nov 30 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics